Clinical Trial Update: A Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of BC3195 in Patients With Advanced or Metastatic Cancer [Phase 1]

View source ↗

Summary

Phase 1 study to assess the safety, pharmacokinetics, and antitumor activity of BC3195 in patients with advanced or metastatic cancer; the trial is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• BC3195

Snippet

Sponsor: Biocity Biopharmaceutics Co., Ltd. | Conditions: Advanced Cancer, Metastatic Solid Tumor | Phase 1 | Status: RECRUITING